Abstract 17287: Increase in Utilization of High-intensity Statin Among New Users After the Release of the 2013 ACC/AHA Cholesterol Management Guideline
| Autor: | Tope Olufade, Deborah Anzalone, David M Kern, Ozgur Tunceli, Siting Zhou, Vince Willey, Mark J Cziraky |
|---|---|
| Rok vydání: | 2015 |
| Předmět: | |
| Zdroj: | Circulation. 132 |
| ISSN: | 1524-4539 0009-7322 |
| DOI: | 10.1161/circ.132.suppl_3.17287 |
| Popis: | Introduction: To characterize changes in statin utilization patterns after the release of the 2013 ACC/AHA cholesterol management guideline. Methods: Using administrative claims and laboratory results data from the HealthCore Integrated Research Database, statin use was captured during the 4 quarters before and after release of the 2013 ACC/AHA guideline. Individuals were classified into 4 statin benefit groups (SBG), as described in the ACC/AHA guideline. Patients new to statins were identified independently during each quarter. Results: An average of 205,358 patients were identified across the 4 SBG groups during each quarter, of whom an average of 3,658 were new statin users. New users were 41% women and 61 years old on average. Results are shown in Figure 1. In SBG 1, high-intensity statin use in patients Conclusions: The 2013 ACC/AHA guideline appeared to have a modest effect in the utilization of high-intensity statins among new users in the period immediately following its release. The increase was most marked in the use of high-intensity statins in ASCVD patients and in patients treated by specialists. Follow-up in future years to assess the impact of the ACC/AHA guideline is warranted. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|